Author:
Batiha Gaber El-Saber,Teibo John Oluwafemi,Shaheen Hazem M.,Babalola Benjamin Ayodipupo,Teibo Titilade Kehinde Ayandeyi,Al-kuraishy Hayder M.,Al-Garbeeb Ali I.,Alexiou Athanasios,Papadakis Marios
Abstract
AbstractLawsonia inermis Linn, commonly known as henna, is a member of the Lythraceae family and has been found to contain a variety of compounds with both industrial and medicinal applications in its stem, bark, roots, flowers, and seeds. This report provides a comprehensive review of the bioactive components, pharmacological activities, pharmacokinetics, and pharmacological side effects of Lawsonia inermis. Relevant materials were gathered from Google Scholar, PubMed, Scopus, and Web of Science and reviewed for important properties and updates about the plant. Lawsonia inermis contains a variety of bioactive compounds, including flavonoids, coumarins, triterpenoids, steroids, xanthones, polyphenols, fatty acids, alkaloids, quinones, tannins, leucocyandin, epicatechin, catechin, and quercetin. The plant is been traditionally used to treat numerous conditions, including ulcers, bronchitis, lumbago, hemicrania, leukoderma, scabies, boils, ophthalmic disorders, hair loss, and jaundice. It has also been found to possess a range of pharmacological activities, including antioxidant, anti-inflammatory, analgesic, antiparasitic, hepatoprotective, antifungal, antitumor, wound healing, and hypoglycemic effects. The potential of Lawsonia inermis for various biological applications is promising, and further studies are needed to fully explore its therapeutic benefits for various diseases of public health. Concern advances in drug development could enable the characterization of various bioactive constituents and facilitate their development and application for the benefit of humanity.
Funder
University of Witten-Herdecke, 42283, Wuppertal, Germany.
Private Universität Witten/Herdecke gGmbH
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,General Medicine
Reference101 articles.
1. Abdessalem O, Wali A, Benzina M (2016) Adsorption of bentazon on activated carbon prepared from Lawsonia inermis wood: equilibrium, kinetic and thermodynamic studies. Arab J Chem 9:S1729–S1739. https://doi.org/10.1016/j.arabjc.2012.06.027
2. Abdelraouf AE, Amany AA, Nedaa AAG (2011) Antibacterial antifungal andsynergistic effect of Lawsonia inermis, Punica granatum and Hibiscussabdariffa. Ann Alquds Med 7:33–41
3. Abdillah S, Budiady I, Winarno H (2008) Hypoglycaemic and antihyperlipidemic effects of henna leaves extract (Lawsonia inermis Linn) on alloxan induced diabetic mice. Jordan J Pharm Sci 1:126–131
4. Abdulmoneim MA (2007) Evaluation of Lawsonia inermis Linn. (sudanese henna) leaf extract as an antimicrobial agent. Res J Biol Sci. 2:417–23
5. Adetobi ET, Akinsuyi SO, Ahmed OA, Folajimi EO, Ayodipupo BB (2022) In silico evaluation of the inhibitory potential of cymbopogonol from cymbopogon citratus towards falcipain-2 (FP2) cysteine protease of plasmodium falciparum. Trop J Nat Prod Res 6(10):1687–1694. https://doi.org/10.26538/tjnpr/v6i10.22